These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9348212)

  • 1. Clearance of 125I-labeled interleukin-6 from brain into blood following intracerebroventricular injection in rats.
    Chen G; Castro WL; Chow HH; Reichlin S
    Endocrinology; 1997 Nov; 138(11):4830-6. PubMed ID: 9348212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms by which blood levels of interleukin-6 (IL-6) are elevated after intracerebroventricular injection of IL-1beta in the rat: neural versus humoral control.
    Chen G; Reichlin S
    Endocrinology; 1999 Dec; 140(12):5549-55. PubMed ID: 10579318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood to brain transfer of leptin in normal and interleukin-1beta-treated male rats.
    Reichlin S; Chen G; Nicolson M
    Endocrinology; 2000 Jun; 141(6):1951-4. PubMed ID: 10830276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 (IL-6) is secreted from the brain after intracerebroventricular injection of IL-1 beta in rats.
    Romero LI; Kakucska I; Lechan RM; Reichlin S
    Am J Physiol; 1996 Mar; 270(3 Pt 2):R518-24. PubMed ID: 8780215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood interleukin-6 and tumor necrosis factor-alpha elevation after intracerebroventricular injection of Escherichia coli endotoxin in the rat is determined by two opposing factors: peripheral induction by LPS transferred from brain to blood and inhibition of peripheral response by a brain-mediated mechanism.
    Chen G; McCuskey RS; Reichlin S
    Neuroimmunomodulation; 2000; 8(2):59-69. PubMed ID: 10965230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clearance of [125I]-tumor necrosis factor-alpha from the brain into the blood after intracerebroventricular injection in rats.
    Chen G; Reichlin S
    Neuroimmunomodulation; 1998; 5(5):261-9. PubMed ID: 9730694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenocorticotropin release induced by intracerebroventricular injection of recombinant human interleukin-1 in rats: possible involvement of prostaglandin.
    Katsuura G; Gottschall PE; Dahl RR; Arimura A
    Endocrinology; 1988 May; 122(5):1773-9. PubMed ID: 2834174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines act within the brain to inhibit luteinizing hormone secretion and ovulation in the rat.
    Rivier C; Vale W
    Endocrinology; 1990 Aug; 127(2):849-56. PubMed ID: 2115435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of gonadotropin-induced testosterone secretion by the intracerebroventricular injection of interleukin-1 beta in the male rat.
    Turnbull AV; Rivier C
    Endocrinology; 1997 Mar; 138(3):1008-13. PubMed ID: 9048602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain interleukin-1 is involved in blood interleukin-6 response to immobilization stress in rats.
    Ishikawa I; Kitamura H; Kimura K; Saito M
    Jpn J Vet Res; 2001 May; 49(1):19-25. PubMed ID: 11521445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Centrally administered interleukin-1 beta sensitizes to the central pressor action of angiotensin II.
    Ufnal M; Dudek M; Zera T; SzczepaƄska-Sadowska E
    Brain Res; 2006 Jul; 1100(1):64-72. PubMed ID: 16765325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A hypothalamic-testicular neural pathway is influenced by brain catecholamines, but not testicular blood flow.
    Selvage DJ; Lee SY; Parsons LH; Seo DO; Rivier CL
    Endocrinology; 2004 Apr; 145(4):1750-9. PubMed ID: 14684600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Causal links between brain cytokines and experimental febrile convulsions in the rat.
    Heida JG; Pittman QJ
    Epilepsia; 2005 Dec; 46(12):1906-13. PubMed ID: 16393156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain IL-1 beta was involved in reserpine-induced behavioral depression in rats.
    Huang QJ; Jiang H; Hao XL; Minor TR
    Acta Pharmacol Sin; 2004 Mar; 25(3):293-6. PubMed ID: 15000880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparison of changes in behavior, neurochemistry, endocrine, and immune functions after different routes, doses and durations of administrations of IL-1beta in rats.
    Song C; Horrobin DF; Leonard BE
    Pharmacopsychiatry; 2006 May; 39(3):88-99. PubMed ID: 16721697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exacerbation of ischemic brain damage by localized striatal injection of interleukin-1beta in the rat.
    Stroemer RP; Rothwell NJ
    J Cereb Blood Flow Metab; 1998 Aug; 18(8):833-9. PubMed ID: 9701344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The intracerebroventricular injection of interleukin-1beta blunts the testosterone response to human chorionic gonadotropin: role of prostaglandin- and adrenergic-dependent pathways.
    Ogilvie K; Rivier C
    Endocrinology; 1998 Jul; 139(7):3088-95. PubMed ID: 9645680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased circulating interleukin-1 and interleukin-6 after intracerebroventricular injection of lipopolysaccharide.
    Gottschall PE; Komaki G; Arimura A
    Neuroendocrinology; 1992 Dec; 56(6):935-8. PubMed ID: 1369606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central administration of IL-1 alpha increases glucose uptake by muscle.
    Jarrous A; Lang CH
    Cytokine; 1995 Jan; 7(1):57-63. PubMed ID: 7749067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1 inhibits the ovarian steroid-induced luteinizing hormone surge and release of hypothalamic luteinizing hormone-releasing hormone in rats.
    Kalra PS; Sahu A; Kalra SP
    Endocrinology; 1990 Apr; 126(4):2145-52. PubMed ID: 2180683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.